Oncology PracticeBRCA1/2 Mutations Tied to Better Ovarian Cancer Survival January 24, 2012Gynecologic Cancer
Oncology PracticeBevacizumab Effective With First-Line Treatment for Ovarian CancerDecember 28, 2011Gynecologic Cancer
Oncology PracticeAflibercept Prevents Ascites Recurrence in Advanced Ovarian CancerDecember 20, 2011Gynecologic Cancer
Oncology PracticeRaised hCG After Molar Pregnancy May Not Mean Malignancy November 28, 2011Gynecologic Cancer
Oncology PracticeHysterectomy No Boon in Early-Stage Ovarian Cancer October 18, 2011Gynecologic Cancer
Oncology PracticeBRCA2 Linked to Better Chemo Response in Ovarian CancerOctober 11, 2011Gynecologic Cancer
Oncology PracticeLess Toxic IMRT Controls Cervical Cancer After HysterectomyOctober 6, 2011Gynecologic Cancer
Oncology PracticeCommentary: Depression Stymies Care in Latina Breast Cancer SurvivorsSeptember 19, 2011Breast CancerGynecologic CancerPatient & Survivor Care
Oncology PracticeATHENA: HPV Testing Outperforms Cytology for Cervical Cancer ScreeningAugust 22, 2011Gynecologic Cancer
Oncology PracticeExperts Advocate Salpingectomy Trial in Ovarian Cancer PreventionAugust 16, 2011Gynecologic Cancer
Oncology PracticeVideo Report: Gynecologic Oncology Highlights From ASCO 2011June 27, 2011Gynecologic Cancer
Oncology PracticeBevacizumab Shows Promise for High-Risk Ovarian CancerJune 5, 2011Gynecologic Cancer
Oncology PracticeBevacizumab Halves Progression Risk in Recurrent Ovarian CancerJune 5, 2011Gynecologic Cancer
